(s4dU)35: A novel, highly potent oligonucleotide inhibitor of the human immunodeficiency virus type 1 reverse transcriptase

FEBS Letters

Volumn 396, Issue 1, 1996, Pages 43-46

  Tokés, Szilvia ^a   Aradi, Janos ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Antitemplate; Human immunodeficiency virus; Inhibition; Oligo 4 thio 2' deoxyuridylate; Reverse transcriptase

Indexed keywords

OLIGONUCLEOTIDE; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; 2'-DEOXYURIDYLIC ACID; DEOXYURIDINE PHOSPHATE; PRIMER DNA; SULFUR;

ARTICLE; DRUG SYNTHESIS; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; CHEMISTRY; DRUG ANTAGONISM;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEOXYURACIL NUCLEOTIDES; DNA PRIMERS; HIV-1 REVERSE TRANSCRIPTASE; OLIGONUCLEOTIDES; REVERSE TRANSCRIPTASE INHIBITORS; STRUCTURE-ACTIVITY RELATIONSHIP; SULFUR;

EID: 0030604918     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-5793(96)01032-0     Document Type: Article

References (28)

1. [1] De Clercq, E. (1992) AIDS Res. Hum. Retroviruses 8, 119-134.
2. [2] Connolly, K.J. and Hammer, S.M. (1992) Antimicrob. Agents Chemother. 36, 245-254.
3. [3] Connolly, K.J. and Hammer, S.M. (1992) Antimicrob. Agents Chemother. 36, 509-520.
4. [4] De Clercq, E. (1993) Med. Res. Rev. 13, 229-258.
5. [5] Althaus, I.W., Chou, K.C., Lemay, R.J., Franks, K.M., Deibel, M.R., Kezdi, F.J., Resnick, L., Busso, M.E., So, A.C., Downey, K.M., Romero, D.L., Thomas, R.C., Aristoff, P.A., Tarpley, W.G. and Reusser, F. (1996) Biochem. Pharmacol. 51, 743-750.
6. [6] Bardos, T.J. and Ho, Y.K. (1982) in: New Approaches to the Design of Antineoplastic Agents (Bardos, T.J. and Kaiman, T.I. eds.), pp. 315-332, Elsevier, New York.
7. [7] Ho, Y.-K., Fiel, R.J., Aradi, J. and Bardos, T.J. (1979) Biochemistry 18, 5630-5635.
8. [8] Ho, Y.-K., Aradi, J. and Bardos, T.J. (1980) Nucleic Acids Res. 14, 3175-3191.
9. [9] Aradi, J. and Ho, Y.-K. (1985) Cancer Biochem. Biophys. 7, 349-359.
10. [10] Bardos, T.J., Schinazi, R.F., Ling, K-H.J. and Heider, A.R. (1992) Antimicrob. Agents Chemother. 36, 108-114.
11. [11] Tokés, S. and Aradi, J. (1995) Biochim. Biophys. Acta 1261, 115-120.
12. [12] Majumdar, C., Stein, Cy.A., Cohen, J.S., Broder, S. and Wilson, S.H. (1989) Biochemistry 28, 1340-1346.
13. [13] Maury, G., Divita, G., Morvan, F., Imbach, J.-L. and Goody, R.S. (1993) Biochim. Biophys. Acta 1216, 1-8.
14. [14] Gao, W., Stein, Cy.A., Cohen, J.S., Dutschman, G.E. and Cheng, Y.-C. (1988) J. Biol. Chem. 264, 11521-11526.
15. [15] Marshall, W.S. and Caruthers, M.H. (1993) Science 259, 1564-1570.
16. [16] Bellon, L., Barascut, J.-L., Maury, G., Divita, G., Goody, R. and Imbach, J.-L. (1993) Nucleic Acids Res. 21, 1587-1593.
17. [17] Smith, J.C., Raper, R.H., Bell, L.D., Stebbing, N. and McGeoch, D. (1980) Virology 103, 245-249.
18. [18] Miura, K., Shiga, M. and Ueda, T. (1973) J. Biochem. 73, 1279-1284.
19. [19] Miura, K. and Ueda, T. (1980) Chem. Pharm. Bull. 28, 3415-3418.
20. [20] Miura, K., Tsuda, S., Iwano, T., Ueda, T., Harada, F. and Kato, N. (1983) Biochim. Biophys. Acta 739, 181-189.
21. [21] Miller, P.S. and Cushman, C.D. (1992) Bioconjugate Chem. 3, 74-79.
22. [22] Chen, P.S., Toribara, T.Y. and Warner, H. (1956) Anal. Chem. 28, 1756-1758.
23. [23] Kohlstaedt, L.A., Wang, J., Friedman, J.M., Rice, P.A. and Steiz, T.A. (1992) Science 256, 1783-1790.
24. [24] Wöhrl, B.M., Tantillo, C, Arnold, E. and Le Grice, S.F.J. (1995) Biochemistry 34, 5343-5350.
25. [25] Hochberg, A.A. and Keren-Zur, M. (1974) Nucleic Acids Res. 1, 1619-1630.
26. [26] Fiser, I., Scheit, K.H., Stoffler, G. and Kuechler, E. (1974) Biochem. Biophys. Res. Commun. 60, 1112-1118.
27. [27] Rittinger, K., Divita, G. and Goody, R.S. (1995) Proc. Natl. Acad. Sci. USA 92, 8046-8049.
28. [28] Jaju, M., Beard, W.A. and Wilson, S.H. (1995) J. Biol. Chem. 270, 9740-9747.